These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10528940

  • 1. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
    Verhoeff NP, Petroff OA, Hyder F, Zoghbi SS, Fujita M, Rajeevan N, Rothman DL, Seibyl JP, Mattson RH, Innis RB.
    Epilepsia; 1999 Oct; 40(10):1433-8. PubMed ID: 10528940
    [Abstract] [Full Text] [Related]

  • 2. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA, Hyder F, Collins T, Mattson RH, Rothman DL.
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [Abstract] [Full Text] [Related]

  • 3. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia.
    Verhoeff NP, Soares JC, D'Souza CD, Gil R, Degen K, Abi-Dargham A, Zoghbi SS, Fujita M, Rajeevan N, Seibyl JP, Krystal JH, van Dyck CH, Charney DS, Innis RB.
    Psychiatry Res; 1999 Oct 11; 91(3):163-73. PubMed ID: 10641580
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of benzodiazepine receptor in the cerebral cortex of Parkinson's disease using 123I-iomazenil SPECT].
    Kawabata K, Tachibana H.
    Nihon Rinsho; 1997 Jan 11; 55(1):244-8. PubMed ID: 9014458
    [Abstract] [Full Text] [Related]

  • 5. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG, Weber OM, Duc CO, Weber B, Meier D, Russ W, Boesiger P, Wieser HG.
    Epilepsia; 2001 Jan 11; 42(1):29-40. PubMed ID: 11207782
    [Abstract] [Full Text] [Related]

  • 6. Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.
    Pinborg LH, Videbaek C, Hasselbalch SG, Sørensen SA, Wagner A, Paulson OB, Knudsen GM.
    J Neurol Neurosurg Psychiatry; 2001 May 11; 70(5):657-61. PubMed ID: 11309461
    [Abstract] [Full Text] [Related]

  • 7. Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT.
    Kugaya A, Sanacora G, Verhoeff NP, Fujita M, Mason GF, Seneca NM, Bozkurt A, Khan SA, Anand A, Degen K, Charney DS, Zoghbi SS, Baldwin RM, Seibyl JP, Innis RB.
    Biol Psychiatry; 2003 Oct 15; 54(8):792-9. PubMed ID: 14550678
    [Abstract] [Full Text] [Related]

  • 8. GABA changes with vigabatrin in the developing human brain.
    Novotny EJ, Hyder F, Shevell M, Rothman DL.
    Epilepsia; 1999 Apr 15; 40(4):462-6. PubMed ID: 10219272
    [Abstract] [Full Text] [Related]

  • 9. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
    Petroff OA, Rothman DL, Behar KL, Mattson RH.
    Epilepsia; 1995 May 15; 36(5):457-64. PubMed ID: 7614922
    [Abstract] [Full Text] [Related]

  • 10. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
    Kawabata K, Tachibana H, Sugita M, Fukuchi M.
    Kaku Igaku; 1996 Apr 15; 33(4):391-7. PubMed ID: 8683878
    [Abstract] [Full Text] [Related]

  • 11. Benzodiazepine receptor distribution in severe intractable tinnitus.
    Daftary A, Shulman A, Strashun AM, Gottschalk C, Zoghbi SS, Seibyl JP.
    Int Tinnitus J; 2004 Apr 15; 10(1):17-23. PubMed ID: 15379343
    [Abstract] [Full Text] [Related]

  • 12. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.
    Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1994 Apr 15; 244(1):49-51. PubMed ID: 7918702
    [Abstract] [Full Text] [Related]

  • 13. Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity.
    Morimoto K, Tamagami H, Matsuda K.
    Epilepsia; 2005 Apr 15; 46 Suppl 5():184-8. PubMed ID: 15987275
    [Abstract] [Full Text] [Related]

  • 14. [Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT].
    Yonekura Y, Nishizawa S, Tanaka F, Ishizu K, Okazawa H, Fujita T, Konishi J, Torizuka K.
    Kaku Igaku; 1995 Jan 15; 32(1):87-97. PubMed ID: 7897872
    [Abstract] [Full Text] [Related]

  • 15. Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration.
    Świąder MJ, Świąder K, Zakrocka I, Krzyżanowski M, Wróbel A, Łuszczki JJ, Czuczwar SJ.
    Pharmacol Rep; 2020 Apr 15; 72(2):322-330. PubMed ID: 32048251
    [Abstract] [Full Text] [Related]

  • 16. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV, Siegel H, Kopylev L, Fazilat S, Dean A, Liow K, Ben-Menachem E, Gaillard WD, Theodore WH.
    Neurology; 1999 Oct 22; 53(7):1518-22. PubMed ID: 10534261
    [Abstract] [Full Text] [Related]

  • 17. Alterations of benzodiazepine receptor binding potential in anxiety and somatoform disorders measured by 123I-iomazenil SPECT.
    Tokunaga M, Ida I, Higuchi T, Mikuni M.
    Radiat Med; 1997 Oct 22; 15(3):163-9. PubMed ID: 9278373
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maturational Changes of Gamma-Aminobutyric Acid A Receptors Measured With Benzodiazepine Binding of Iodine 123 Iomazenil Single-Photon Emission Computed Tomography.
    Ikemoto S, Hamano SI, Hirata Y, Matsuura R, Kikuchi K.
    Pediatr Neurol; 2018 May 22; 82():19-24. PubMed ID: 29625846
    [Abstract] [Full Text] [Related]

  • 20. Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex.
    Mori K, Mori T, Toda Y, Fujii E, Miyazaki M, Harada M, Kagami S.
    Brain Dev; 2012 Jun 22; 34(6):478-86. PubMed ID: 21959128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.